Caris and Merck partner to develop ADCs for cancer treatment

Caris Life Sciences has entered a collaboration with Merck KGaA for the development of antibody-drug conjugates (ADCs) for cancer.

Related Keywords

Germany ,South Korea ,Daejeon ,Taejon Gwangyoksi ,Brian Lamon ,Caris ,Company Profile ,Company Profiles ,Merck Kgaa ,Merck Kga ,Caris Life Science ,Caris Discovery ,